Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13

di Fehniger, Todd A., Byrd, John C., Marcucci, Guido, Abboud, Camille N., Kefauver, Cheryl, Payton, Jacqueline E., Vij, Ravi, Blum, William
Pubblicazione 2009

A Phase II trial of Bevacizumab and High Dose Interferon Alpha-2B in Metastatic Melanoma

di Grignol, Valerie P., Olencki, Thomas, Relekar, Kiran, Taylor, Cynthia, Kibler, Amanda, Kefauver, Cheryl, Wei, Lai, Walker, Michael J., Chen, Helen X., Kendra, Kari, Carson, William E.
Pubblicazione 2011

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

di Klisovic, Rebecca B., Blum, William, Liu, Zhongfa, Xie, Zhiliang, Kefauver, Cheryl, Huynh, Lenguyen, Zwiebel, James A., Devine, Steven M., Byrd, John C., Grever, Michael R., Chan, Kenneth K., Marcucci, Guido
Pubblicato in Leuk Lymphoma (2013)

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

di Sadeghi, Sarmad, Groshen, Susan G., Tsao-Wei, Denice D., Parikh, Rahul, Mortazavi, Amir, Dorff, Tanya B., Kefauver, Cheryl, Hoimes, Christopher, Doyle, Laurence, Quinn, David I., Newman, Edward, Lara Jr, Primo N.
Pubblicato in J Clin Oncol (2019)

Pharmacokinetics and Dose Escalation of the Heat Shock Protein Inhibitor 17-AAG in Combination with Bortezomib in Relapsed or Refractory Acute Myeloid Leukemia

di Walker, Alison R., Klisovic, Rebecca, Johnston, Jeffrey S., Jiang, Yao, Geyer, Susan, Kefauver, Cheryl, Binkley, Philip, Byrd, John C., Grever, Michael R., Garzon, Ramiro, Phelps, Mitch A., Marcucci, Guido, Blum, Kristie A., Blum, William
Pubblicazione 2013

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia()

di Maddocks, Kami, Ruppert, Amy S., Browning, Rebekah, Jones, Jeffrey, Flynn, Joseph, Kefauver, Cheryl, Gao, Yue, Jiang, Yao, Rozewski, Darlene M., Poi, Ming, Phelps, Mitch A., Harper, Erica, Johnson, Amy J., Byrd, John C., Andritsos, Leslie A.
Pubblicato in Leuk Res (2014)

A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer

di Martin, Ludmila Katherine, Grecula, John, Jia, Guang, Wei, Lai, Yang, Xiangyu, Otterson, Gregory A., Wu, Xin, Harper, Erica, Kefauver, Cheryl, Zhou, Bing-Sen, Yen, Yun, Bloomston, Mark, Knopp, Michael, Ivy, S. Percy, Grever, Michael, Bekaii-Saab, Tanios
Pubblicazione 2012

Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia

di Klisovic, Rebecca B., Blum, William, Wei, Xiaohui, Liu, Shujun, Liu, Zhongfa, Xie, Zhiliang, Vukosavljevic, Tamara, Kefauver, Cheryl, Huynh, LeNguyen, Pang, Jiuxia, Zwiebel, James A., Devine, Steven, Byrd, John C., Grever, Michael R., Chan, Kenneth, Marcucci, Guido
Pubblicazione 2008

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias

di Blum, William, Phelps, Mitch A., Klisovic, Rebecca B., Rozewski, Darlene M., Ni, Wenjun, Albanese, Katie A., Rovin, Brad, Kefauver, Cheryl, Devine, Steven M., Lucas, David M., Johnson, Amy, Schaaf, Larry J., Byrd, John C., Marcucci, Guido, Grever, Michael R.
Pubblicazione 2010

Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia

di Andritsos, Leslie A., Johnson, Amy J., Lozanski, Gerard, Blum, William, Kefauver, Cheryl, Awan, Farrukh, Smith, Lisa L., Lapalombella, Rosa, May, Sarah E., Raymond, Chelsey A., Wang, Da-Sheng, Knight, Robert D., Ruppert, Amy S., Lehman, Amy, Jarjoura, David, Chen, Ching-Shih, Byrd, John C.
Pubblicato in J Clin Oncol (2008)

Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias

di Blum, William, Klisovic, Rebecca B., Becker, Heiko, Yang, Xiaoxia, Rozewski, Darlene M., Phelps, Mitch A., Garzon, Ramiro, Walker, Alison, Chandler, Jason C., Whitman, Susan P., Curfman, John, Liu, Shujun, Schaaf, Larry, Mickle, Jon, Kefauver, Cheryl, Devine, Steven M., Grever, Michael R., Marcucci, Guido, Byrd, John C.
Pubblicazione 2010

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

di Blum, William, Garzon, Ramiro, Klisovic, Rebecca B., Schwind, Sebastian, Walker, Alison, Geyer, Susan, Liu, Shujun, Havelange, Violaine, Becker, Heiko, Schaaf, Larry, Mickle, Jon, Devine, Hollie, Kefauver, Cheryl, Devine, Steven M., Chan, Kenneth K., Heerema, Nyla A., Bloomfield, Clara D., Grever, Michael R., Byrd, John C., Villalona-Calero, Miguel, Croce, Carlo M., Marcucci, Guido
Pubblicazione 2010

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia

di Blum, William, Schwind, Sebastian, Tarighat, Somayeh S., Geyer, Susan, Eisfeld, Ann-Kathrin, Whitman, Susan, Walker, Alison, Klisovic, Rebecca, Byrd, John C., Santhanam, Ramasamy, Wang, Hongyan, Curfman, John P., Devine, Steven M., Jacob, Samson, Garr, Celia, Kefauver, Cheryl, Perrotti, Danilo, Chan, Kenneth K., Bloomfield, Clara D., Caligiuri, Michael A., Grever, Michael R., Garzon, Ramiro, Marcucci, Guido
Pubblicazione 2012